Condition
Squamous Non-Small Cell Lung Cancer (NSCLC) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Squamous Non-Small Cell Lung Cancer (NSCLC) clinical trials that are recruiting, at sites in 3 countries (most in Australia (1), France (1), United Kingdom (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
ZI-MA4-1 cell therapy for hard-to-treat solid cancers
This early-stage trial tests ZI-MA4-1, an allogeneic cell therapy, in patients with inoperable locally advanced or metastatic ovarian cancer, squamous NSCLC, synovial sarcoma, or head and neck cancer to see if it is safe and tolerable and to find a recommended dose.
-
Assessing safety and efficacy of new treatments for advanced solid tumors
This study is testing two new treatments for patients with advanced solid tumors to see if they are safe and effective.
Related topics
Quick answers
How many Squamous Non-Small Cell Lung Cancer (NSCLC) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (1 trial), France (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.